Page 795 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

28. Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid 43. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data
CR. Nosocomial infections in surgical patients in the United on the therapy and outcome of ventilator-associated pneumo-
States, January 1986-June 1992. National Nosocomial Infections nia. Chest. 1997;111:676-685.
Surveillance (NNIS) System. Infect Control Hosp Epidemiol. 44. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropri-
1993;14:73-80. ateness of initial antibiotic therapy on the outcome of ventilator-
29. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors associated pneumonia. Intensive Care Med. 2001;27:355-362.
for ventilator-associated pneumonia in critically ill patients [see 45. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre
comments]. Ann Intern Med. 1998;129:433-440. J. Early predictors for infection recurrence and death in
30. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun- patients with ventilator-associated pneumonia. Crit Care Med.
Buisson C. Lower respiratory tract colonization and infection 2007;35:146-154.
during severe acute respiratory distress syndrome: incidence 46. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J.
and diagnosis. Am J Respir Crit Care Med. 1997;156:1092-1098. Attributable mortality due to nosocomial infections. A simple
31. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospec- and useful application of multistate models. Methods Inf Med.
tive study of ventilator-associated pneumonia during acute 2007;46:595-600.
respiratory distress syndrome. Incidence, prognosis, and risk 47. Bekaert M, Timsit JF, Vansteelandt S, et al. Attributable mor-
factors. ARDS Study Group. Am J Respir Crit Care Med. tality of ventilator associated pneumonia: a reappraisal using
2000;161:1942-1948. causal analysis. Am J Respir Crit Care Med. 2011.
32. Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in 48. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and eco-
acute respiratory distress syndrome. A prospective evaluation nomic consequences of ventilator-associated pneumonia: a
of bilateral bronchoscopic sampling. Am J Respir Crit Care Med. systematic review. Crit Care Med. 2005;33:2184-2193.
1998;158:870-875.
33. Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated 49. Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical
and economic outcomes attributable to health care-associated
pneumonia and mortality: a systematic review of observational sepsis and pneumonia. Arch Intern Med. 2010;170:347-353.
studies. Crit Care Med. 2009.
34. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert 50. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson
C. The attributable morbidity and mortality of ventilator-
C. Nosocomial pneumonia in ventilated patients: a cohort study associated pneumonia in the critically ill patient. The Canadian
evaluating attributable mortality and hospital stay. Am J Med. Critical Trials Group. Am J Respir Crit Care Med. 1999;159:1249-
1993;94:281-288. 1256.
35. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert 51. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated
C. Nosocomial pneumonia and mortality among patients in trauma patients. Microbiology and outcomes. Am J Respir Crit
intensive care units. JAMA. 1996;275:866-869. Care Med. 1996;153:343-349.
36. Kollef MH. Ventilator-associated pneumonia. A multivariate 52. Muscedere JG, Martin CM, Heyland DK. The impact of ventila-
analysis. JAMA. 1993;270:1965-1970. tor-associated pneumonia on the Canadian health care system. J
37. Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, Crit Care. 2008;23:5-10.
Schaffino-Cano S, Galvez-Vargas R. Influence of nosocomial 53. Peleg AY, Hooper DC. Hospital-acquired infections due to
infection on mortality rate in an intensive care unit. Crit Care gram-negative bacteria. N Engl J Med. 2010;362:1804-1813.
Med. 1994;22:55-60.
38. Nguile-Makao M, Zahar JR, Francais A, et al. Attributable 54. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and out-
comes of ventilator-associated pneumonia in a large US data-
mortality of ventilator-associated pneumonia: respective impact base. Chest. 2002;122:2115-2121.
of main characteristics at ICU admission and VAP onset using
conditional logistic regression and multi-state models. Intensive 55. Burgmann H, Hiesmayr JM, Savey A, Bauer P, Metnitz B,
Care Med. 2010;36:781-789. Metnitz PG. Impact of nosocomial infections on clinical
39. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al. Impact outcome and resource consumption in critically ill patients.
Intensive Care Med. 2010;36:1597-1601.
of invasive and noninvasive quantitative culture sampling on
outcome of ventilator-associated pneumonia: a pilot study [see 56. Kollef MH, Morrow LE, Niederman MS, et al. Clinical charac-
comments] [published erratum appears in Am J Respir Crit teristics and treatment patterns among patients with ventilator-
Care Med 1998 Mar;157(3 Pt 1):1005]. Am J Respir Crit Care associated pneumonia. Chest. 2006;129:1210-1218.
Med. 1998;157:371-376. 57. Rello J, Diaz E, Rodriguez A. Etiology of ventilator-associated
40. Ruiz M, Torres A, Ewig S, et al. Noninvasive versus inva- pneumonia. Clin Chest Med. 2005;26:87-95.
sive microbial investigation in ventilator-associated pneumo- 58. Combes A, Figliolini C, Trouillet JL, et al. Incidence and out-
nia: evaluation of outcome. Am J Respir Crit Care Med. come of polymicrobial ventilator-associated pneumonia. Chest.
2000;162:119-125. 2002;121:1618-1623.
41. Alvarez-Lerma F. Modification of empiric antibiotic treatment 59. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated
in patients with pneumonia acquired in the intensive care unit. pneumonia caused by potentially drug-resistant bacteria. Am J
ICU-Acquired Pneumonia Study Group. Intensive Care Med. Respir Crit Care Med. 1998;157:531-539.
1996;22:387-394. 60. Giantsou E, Liratzopoulos N, Efraimidou E, et al. Both early-
42. Kollef MH. Antimicrobial therapy of ventilator-associated onset and late-onset ventilator-associated pneumonia are
pneumonia: how to select an appropriate drug regimen [edito- caused mainly by potentially multiresistant bacteria. Intensive
rial; comment]. Chest. 1999;115:8-11. Care Med. 2005.

Section04-O-ref.indd 2 1/21/2015 11:23:24 AM